Ziosoft to Feature ECVct and LAAO Advanced Visualization at American College of Cardiology Annual Convention
Summary
“Recent studies have shown that the analysis of amyloidosis using ECVct and AV software can reliably detect dual AS-amyloid pathology in potential TAVR patients, “ said Rajeev Taitriya, vice president of marketing and business development for Ziosoft. “With only an additional three minutes on top of the standard CT imaging evaluation and a small radiation burden, Ziosoft’s AV software with measured ECVct not only detects the issue but also tracks the degree of infiltration. This could lead to more rapid and precise diagnoses of this disease.” More than one in five patients undergoing TAVR (Transcatheter Aortic Valve Replacement) have amyloidosis, which is a build up of amyloid protein in organs, interfering with their function. “We believe that we can empower the patient care team with Ziosoft’s advanced software, which offers automated cardiac and atrial appendage segmentation for sizing and planning of LAAO procedures,” said Taitriya. The company also recently introduced Zioflex, a monthly subscription program designed to provide a risk free introduction of Ziosoft’s many AV clinical applications.